BSN Capital Partners’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-43,400
Closed -$11.8M – 20
2021
Q4
$11.8M Buy
+43,400
New +$14.7M 0.75% 19

Other funds holding ONC

BSN Capital Partners's ONC Position: Q1 2022 in Review

BSN Capital Partners sold out of BeOne Medicines (ONC) in Q1 2022, closing a stake of 43,400 shares — an estimated $11.8M sold.

BSN Capital Partners first reported a position in ONC in Q4 2021 and held it in 1 quarter. The position peaked at $11.8M in Q4 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.

  • BSN Capital Partners reported no remaining BeOne Medicines position as of Q1 2022 after selling out during the quarter.
  • BSN Capital Partners sold 43,400 BeOne Medicines shares in Q1 2022, an estimated $11.8M.
  • BSN Capital Partners first reported a position in BeOne Medicines in Q4 2021 and held it in 1 quarter.
  • BSN Capital Partners's BeOne Medicines position peaked at $11.8M in Q4 2021.
  • 239 funds tracked by Wall St. Rank held BeOne Medicines as of Q1 2022.

Based on BSN Capital Partners's 13F filing for Q1 2022.